|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Industry Insight
PMPS Industry Advisor, Robert Harris, claims that pharma manufacturing processes are steadfast due to a fear of adopting alternative technologies. He also highlights a number of articles in this edition that focus on this.
|
|
|
|
Continuous vs Batch Manufacturing
Making the Switch
EU Automation’s Jonathan Wilkins discusses the downfalls of transitioning from batch to continuous manufacturing, but also suggests that a number of benefits outweigh these.
|
|
|
Developing Continuous Manufacturing
Levelling Up
Malvern Panalytical’s Alon Vaisman and Martin Warman Consultancy’s Martin Warman examine the equipment required to implement continuous manufacturing processes.
|
|
|
|
|
Controlled Temperature Transport
Reduce, Reuse, Recycle
Pharma laboratories are seeking more efficient packaging solutions to keep on top of the rising volume of regulations, explains Yann Martin at EMBALL'ISO Group.
|
|
|
|
|
Respiratory, Nasal and Injectable Technologies
Cross-Over Tech
Aptar Pharma’s Dr Gerallt Williams recommends that the industry looks to drug delivery areas such as injectables and nasal delivery devices for solutions when faced with respiratory technology challenges.
|
|
|
|
Clean Room Considerations
Sterilisation Steels
Stainless steel has many hygenic qualities, but the various grades offer different
benefits. Which grades are the most appropriate for particular scenarios? Sue Springett at Teknomek answers.
|
|
|
|
RFID Labelling for Trials
High Demands
Faubel’s Anthony Morrow highlights the benefits of radio-frequency identification technology implementation within labelling to create stronger clinical trial supply chains.
|
|
|
|
Event Review
Inspiring Innovation
The PPMA Show returned this year at Birmingham’s NEC between 26-28 September, bringing many industry experts together to discuss and learn more about processing and packaging machinery.
|
|
|
|
Child-Resistant Packaging
Looking After Little Ones
Origin Pharma Packaging’s Richard Quelch outlines the difference between child-resistant and child-proof packaging, analysing the regulations in place that ensure child-proofing standards are maintained.
|
|
|
The Potential of Packaging
More than Boxes and Bottles
Patient nonadherence can be linked to poor packaging. Oliver Pittock at Valley Northern investigates the current state of compliance and how it can be guaranteed through industry standards.
|
|
|
|
|
| In this edition, ICT Editor Dr Graham Hughes offers PMPS insight on the ramifications of the new EU regulations that are cracking down on counterfeit medications. |
|
|
|
Q&A: Packaging Adherence
Convenience, Compliance and Cartons
PMPS discusses compliance and packaging-related concerns with August Faller Group’s Dr Daniel Keesman, in light of the company’s win at Pharmapack 2017.
|
|
|
Pills, Deterrence and Compliance
Smart Systems
Dr Neil D Theise and Randice Altschul at Pop Test, Dr Razvan Ene at Elco Group and Dr Mark A Prendergast at the University of Kentucky examine the potential of a ‘smart pill’.
|
|
|
|
|
Industry 4.0
Pharma’s Digital Journey
Industry 4.0 focuses on digitalisation, which will enhance productivity, competitiveness and business value. Alwyn Jones at Siemens UK & Ireland explores this further.
|
|
|
|
|
Developing Highly Potent APIs
Handling Hazards
Aptuit’s Carla Brandolini, Jean-Francois Carniaux, Mario Maio and Iain Rusling weigh up the best practices companies can adopt when developing highly potent active pharmaceutical ingredients.
|
|
|
The REACH Regulation
Supervising Substances
Meeting REACH’s standards has been a considerable hurdle for companies. While aiming to protect people from hazardous chemicals, its extensive rules and regulations
complicate procedures, claims Farmak’s Jana Osičková.
|
|
|
|
|
DSCSA Enforcement Delay
What Now?
Justin Schroeder at PCI Pharma Services states that, while it has jumpstarted serialisation practices, the implementation of the FDA’s DSCSA is often delayed due to gaps in the legislation.
|
|
|
Serialisation Software Validation
Redefining Processes
Automating serialisation software validation processes has become ever more crucial due to the constant changes in the market and regulations, as Dan Walles and Lisa Reinhold at TraceLink point out.
|
|
|
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine
Keele, UK and Matfors, Sweden, 30 March 2020: Cobra Biologics (Cobra), an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet (KI), one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic. Partners in the consortium also include Karolinska University Hospital, Public Health Authority (FoHM), IGEA, Adlego AB and Giessen University.
More info >> |
|
 |
White Papers |
 |
|
Accelerating the Time from DNA to Material
Merck
Cell line development is a critical step in upstream process development for monoclonal antibodies (mAbs). Unfortunately, the search for the bestproducing clone can be labor- and resource-intensive and is often compared with looking for a needle in a haystack. Cells must first be engineered to produce the biologic of interest and the cell line generated from a high producing clone must deliver a sufficiently high titer to support clinical studies, and ultimately commercialization of the therapeutic.
More info >> |
|
 |
Industry Events |
 |
World Vaccine Congress Europe
18-21 October 2020, Barcelona, Spain
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >> |
|
|
